Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus

Figure 1

Comparison of the serum levels of anti-GAPDH autoantibodies between SLE patients and HC. (a) Serum anti-GAPDH autoantibodies were higher in total SLE patients versus HC. (b) Serum anti-GAPDH autoantibodies were significantly increased in NPSLE patients and in non-NPSLE patients versus HC.

(a)

(b)